LM Pay

LM Pay FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of LM Pay (Y00.BE) as of Oct 24, 2026 is -1.46 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -2,220.66 % — a change of -99.93% (higher).

FCF Conversion

-1.46 %

YoY

-99.93%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of LM Pay is 2023 -1.46 % . FCF Conversion Rate (FCF/EBITDA) of LM Pay was 2022 -2,220.66 % . It decreases by -99.93% higher compared to the previous year.

The LM Pay FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2021
162.27 PLN
Jan 1, 2022
-2,220.66 PLN
Jan 1, 2023
-1.46 PLN
The LM Pay FCF Conversion history
YEARFCF ConversionYoY
-1.46 %-99.93%
-2,220.66 %-1,468.53%
162.27 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LM Pay Stock analysis

What does LM Pay do? LM Pay SA generates revenue through its MediRaty financing and installment payment system, which targets consumers seeking medical and veterinary services. The company partners with clinics offering specialized treatments like dentistry, plastic surgery, and orthopedics, enabling patients to finance procedures such as dental implants, liposuction, and breast augmentation through MediRaty or MediPay programs. These services are available at both partner facilities and non-partner locations, with financing options tailored to cover costs in fields including ophthalmology, gynecology, and veterinary care. The firm monetizes by facilitating installment payments for medical and veterinary expenses without direct ownership of the services provided. The primary customers are individuals requiring medical treatments or veterinary services, with the company focusing on high-cost procedures such as orthodontic braces, implant prosthetics, and aesthetic surgeries. LM Pay SA’s revenue model relies on transaction fees from clinics and service providers that utilize its financing platforms, rather than direct consumer payments. This approach allows the company to serve a broad segment of consumers seeking accessible financing for healthcare without bearing the risk of the medical services themselves. MediRaty and MediPay programs are designed to integrate seamlessly with clinics' operations, providing patients with flexible payment options. The company’s revenue streams are derived from the financial institutions or healthcare providers that adopt its systems, as these partners pay for access to the financing infrastructure. This business model ensures consistent income from established healthcare and veterinary service providers across Poland, supporting the expansion of affordable healthcare financing options for end-users. LM Pay is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LM Pay stock

FCF Conversion Rate (FCF/EBITDA) of LM Pay is -1.46 % in 2023.

FCF Conversion Rate (FCF/EBITDA) of LM Pay changed from -2,220.66 % to -1.46 %, representing a -99.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) LM Pay since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s LM Pay with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — LM Pay

All Key Metrics — LM Pay